Onshoring the Manufacture of Your Drug Products Soon? FDA Wants To Hear From You!
The FDA has announced the establishment of a public docket to receive comments on issues related to accelerating the establishment of new pharmaceutical manufacturing facilities in the US. You can read the full docket announcement here. Not only is the Agency opening a docket for comment, but that same announcement included information on a public […]
